Cumulative inflammation associates with asymmetric dimethylarginine in rheumatoid arthritis: a 6 year follow-up study
出版年份 2014 全文链接
标题
Cumulative inflammation associates with asymmetric dimethylarginine in rheumatoid arthritis: a 6 year follow-up study
作者
关键词
-
出版物
RHEUMATOLOGY
Volume 54, Issue 7, Pages 1145-1152
出版商
Oxford University Press (OUP)
发表日期
2014-09-05
DOI
10.1093/rheumatology/keu349
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- eNOS Uncoupling in Cardiovascular Diseases - the Role of Oxidative Stress and Inflammation
- (2014) Susanne Karbach et al. CURRENT PHARMACEUTICAL DESIGN
- Disparate effects of anti-TNF-α therapies on measures of disease activity and mediators of endothelial damage in ankylosing spondylitis
- (2014) Mariusz Korkosz et al. Pharmacological Reports
- Asymmetric dimethylarginine and arginine levels in patients with rheumatoid arthritis
- (2014) Husamettin Vatansev et al. Turkish Journal of Biochemistry-Turk Biyokimya Dergisi
- Cardiovascular disease in autoimmune rheumatic diseases
- (2013) Ivana Hollan et al. AUTOIMMUNITY REVIEWS
- Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study
- (2013) Andrzej Surdacki et al. Cardiovascular Diabetology
- Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study
- (2013) Olga Kruszelnicka et al. Cardiovascular Diabetology
- Derangement of hemostasis in rheumatoid arthritis: association with demographic, inflammatory and metabolic factors
- (2013) Theodoros Dimitroulas et al. CLINICAL RHEUMATOLOGY
- Predictors of asymmetric dimethylarginine levels in patients with rheumatoid arthritis: the role of insulin resistance
- (2013) T Dimitroulas et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Usefulness of Risk Scores to Estimate the Risk of Cardiovascular Disease in Patients With Rheumatoid Arthritis
- (2012) Cynthia S. Crowson et al. AMERICAN JOURNAL OF CARDIOLOGY
- Endogenous Nitric Oxide Synthase Inhibitors in the Biology of Disease
- (2012) Ben Caplin et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The l-arginine/asymmetric dimethylarginine ratio is improved by anti-Tumor Necrosis Factor–α therapy in inflammatory arthropathies. Associations with aortic stiffness
- (2012) Kristin Angel et al. ATHEROSCLEROSIS
- Do cardiac risk factors affect the homocysteine and asymmetric dimethylarginine relationship in patients with coronary artery diseases?
- (2012) Özben O. Işıklar et al. CLINICAL BIOCHEMISTRY
- Clinical remission following treatment with tumour necrosis factor-alpha antagonists is not accompanied by changes in asymmetric dimethylarginine in patients with rheumatoid arthritis
- (2012) Aamer Sandoo et al. CLINICAL BIOCHEMISTRY
- Asymmetric Dimethylarginine as a Surrogate Marker of Endothelial Dysfunction and Cardiovascular Risk in Patients with Systemic Rheumatic Diseases
- (2012) Theodoros Dimitroulas et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis
- (2012) K. P. Liao et al. RHEUMATOLOGY
- Prevalence of Traditional Modifiable Cardiovascular Risk Factors in Patients with Rheumatoid Arthritis: Comparison with Control Subjects from the Multi-Ethnic Study of Atherosclerosis
- (2012) Cecilia P. Chung et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study
- (2012) Aamer Sandoo et al. ARTHRITIS RESEARCH & THERAPY
- Systemic inflammation is linked to low arginine and high ADMA plasma levels resulting in an unfavourable NOS substrate-to-inhibitor ratio: the Hoorn Study
- (2011) Leonard P. van der Zwan et al. CLINICAL SCIENCE
- Role of Asymmetrical Dimethylarginine in Inflammation-Induced Endothelial Dysfunction in Human Atherosclerosis
- (2011) Charalambos Antoniades et al. HYPERTENSION
- Vascular function and morphology in rheumatoid arthritis: a systematic review
- (2011) Aamer Sandoo et al. RHEUMATOLOGY
- The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases
- (2010) Fabiola Atzeni et al. AUTOIMMUNITY REVIEWS
- Plasma asymmetric dimethylarginine (ADMA) levels and atherosclerotic disease in ankylosing spondylitis: a cross-sectional study
- (2010) Gian Luca Erre et al. CLINICAL RHEUMATOLOGY
- Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications
- (2010) Armen Yuri Gasparyan et al. RHEUMATOLOGY INTERNATIONAL
- Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography
- (2009) Erdal Cavusoglu et al. ATHEROSCLEROSIS
- Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community
- (2009) Rainer H. Böger et al. CIRCULATION
- Dimethylarginines: their vascular and metabolic roles in Africans and Caucasians
- (2009) Aletta E Schutte et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Arterial stiffness and cumulative inflammatory burden in rheumatoid arthritis: a dose–response relationship independent of established cardiovascular risk factors
- (2009) Michael A. Crilly et al. RHEUMATOLOGY
- Role of Inflammation in Atherosclerosis Associated with Rheumatoid Arthritis
- (2008) Peter Libby AMERICAN JOURNAL OF MEDICINE
- Why do people with rheumatoid arthritis still die prematurely?
- (2008) S E Gabriel ANNALS OF THE RHEUMATIC DISEASES
- Asymmetric Dimethylarginine Independently Predicts Fatal and Nonfatal Myocardial Infarction and Stroke in Women
- (2008) Tora Leong et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started